Key result
Microfluidic devices provide a rapid, small-volume method to monitor in vitro thrombus formation under controlled flow conditions, though accurate clinical validation studies are still missing.
Design
Review
Authors
Loading...
Should not yet change clinical thrombus monitoring; leaves open utility of microfluidic devices pending validation.
Microfluidic devices present a promising, rapid method for monitoring in vitro thrombus formation using small blood volumes, though clinical validation is still required before widespread use.
Westein et al. (2012) conducted a review in Cardiovascular disease. Microfluidic devices was evaluated. Microfluidic devices provide a rapid, small-volume method to monitor in vitro thrombus formation under controlled flow conditions, though accurate clinical validation studies are still missing.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: